NEW DIRECTIONS SERIES:
SURVIVING and THRIVING with HER2+ BREAST CANCER
Oct. 24, 2017
Ceruti's Banquet and Event Center
6325 Illinois Road
Fort Wayne, IN 46818
Keynote presentation and Q&A session featuring Dennis Slamon, MD.
Dennis J. Slamon, MD, PhD, serves as director of clinical/translational research, and as a director of the Revlon/UCLA Women's Cancer Research Program at the UCLA Jonsson Comprehensive Cancer Center. For 12 years, Dr. Slamon and his colleagues conducted the laboratory and clinical research that led to the development of the new breast cancer drug Herceptin, which targets a specific genetic alteration found in about 25 percent of breast cancer patients.
5:45-6:30 p.m. - Registration and refreshments
Rachael Hayes, MD*
Breast Surgical Oncologist
Lutheran Medical Group
Breast Cancer Survivor
Genomic Profiling in Community Practice: Ensuring the Right Test for the Right Patient at the Right Time
Pranil Chandra, DO
Director of Molecular Pathology Services
Update on Breast Cancer Research at the Lutheran Cancer Center
Sunil Babu, MD**
Fort Wayne Medical Oncology and Hematology
Molecular Diversity of Human Breast Cancers: Diagnostic and Therapeutic Implications
Dennis Slamon, MD, PhD
Director, UCLA Women's Cancer Research Program
Director of Clinical/Translational Research
Jonsson Comprehensive Cancer Center
*Member of the medical staff of Lutheran Hospital.
**Independent member of the medical staff of Lutheran Hospital.
Seminar Objectives:At the conclusion, participants will be able to:
- Discuss the biology of HER2+ breast cancer.
- Develop strategies for efficient diagnosis and treatment planning for HER2+ breast cancer.
CMEs and CNEs Available
2.0 contact hours will be awarded.
Continuing Medical and Nursing Education Credits
Fort Wayne Medical Education Program is accredited by the Indiana State Medical Association to provide continuing medical education for physicians.
FWMEP designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Lutheran Health Network is an approved provider of continuing nursing education by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. (OBN-001-91) (OH-420, 6/1/2019)
No one involved in the creation of education content for this CME activity has any relevant financial relationship/interest in the event. This includes event planners, speakers and moderators. No commercial support was provided for this event
Sponsored by the Lutheran Cancer Center, Fort Wayne Medical Education Program and Fort Wayne Medical Oncology and Hematology